NCT03150238

Brief Summary

The project will consist of a multicentre, prospective, observational study with a total duration of 24 months. Clinical, endoscopic and ultrasound data will be collected in a dedicated database (on IG-IBD Register), which will be used to identify potential clinical, endoscopic and ultrasound risk factors of re-operation. These data could be merged into a shared score, to stratify patients according to the risk of post-surgical re- operation and to define an optimal therapeutic management in the post- operative period. Approximately 220 adult patients, with a defined diagnosis of CD, who underwent a surgery for CD in the previous 6 months will be enrolled.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 13, 2017

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

May 10, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 12, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
Last Updated

May 12, 2017

Status Verified

May 1, 2017

Enrollment Period

1.8 years

First QC Date

May 10, 2017

Last Update Submit

May 11, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Re-operation rate in CD patients who underwent surgery for the first time - Re-operation rate

    re-operation rate

    12 months

Secondary Outcomes (1)

  • Ideation of a new score for the risk of re-operation in CD patients

    12 months

Other Outcomes (1)

  • Wall sonographic thickness

    12 months

Study Arms (1)

Post-operative Crohn Disease patients

Adult patients, with a defined diagnosis of CD, who underwent a surgery for CD in the previous 6 months

Other: observation of prognostic factors for relapse

Interventions

The identification of the most relevant prognostic factors and the definition of their weight in predict the risk of re-intervention will be the basis for the definition of a combined score

Post-operative Crohn Disease patients

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients, with a defined diagnosis of CD, who underwent a surgery for CD in the previous 6 months

You may qualify if:

  • Male and female patients aged 18 to 65 years, inclusive
  • Diagnosis of Crohn's Disease (CD) for at least 6 months prior to enrolment, by clinical, endoscopic and histopathologic evidence
  • First surgery for CD performed less than 6 months before enrolment (no second surgery allowed)
  • Ability to provide written informed consent and to be compliant with the schedule of protocol assessments

You may not qualify if:

  • Diagnosis of ulcerative colitis or indeterminate colitis
  • Crohn's disease isolated at stomach, duodenum, jejunum, or perianal region, without ileo-colonic involvement
  • More than one surgery for luminal CD
  • Current stoma or need for ileostomy or colostomy
  • Clinically relevant diseases making interpretation of the trial difficult or that would put the patient at risk of severe complications, in the opinion of the investigator
  • Inability to provide written informed consent and poor compliance with the schedule of protocol assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Clinico Humanitas

Rozzano, MI, 20089, Italy

RECRUITING

MeSH Terms

Conditions

Crohn Disease

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Officials

  • Federica Furfaro, MD, phD

    Istituto Clinico Humanitas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Federica Furfaro, MD, PhD

CONTACT

Silvio Danese, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2017

First Posted

May 12, 2017

Study Start

April 13, 2017

Primary Completion

January 31, 2019

Study Completion

May 31, 2019

Last Updated

May 12, 2017

Record last verified: 2017-05

Locations